Michael Baumgartner - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Michael Baumgartner's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Michael Baumgartner

Michael Baumgartner

Verified

Columnist, ALPENFEUILLETON

Innsbruck

Final Covers

pr news, Advertising , Marketing, Lifestyle, technology business news

Doesn’t Cover

general news,

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 263

  • Navigating parental hesitancy in public health: the case for RSV immunization in newborns - Journal of Perinatology

    By Michael Baumgartner Verified, Mara Schneider, Henrike Rieger| Nature Verified AbstractRespiratory syncytial virus (RSV) poses a significant risk to newborns, particularly during the first months of life, and remains a leading cause of pediatric hospitalization in Germany. Despite the approval of innovative immunoprophylaxis methods like nirsevimab, parental hesitancy persists, driven by knowledge gaps and concerns about safety.

    By Michael Baumgartner Verified, Mara Schneider, Henrike Rieger · Nature

    Apr. 10, 2025

  • GSC zum elften Mal ungeschlagen - Pentenrieds Serie gerissen

    By Michael Baumgartner Verified| TZ@ tzSportAmateureDer Gautinger SC spielt gegen die SpVgg Wildenroth Unentschieden – und ist zum elften Mal ungeschlagen. Pentenrieds Serie ist dagegen gerissen. Gautinger SC –SpVgg Wildenroth⇥3:3 (1:2)Tore: 1:0 Meyer (4.), 1:1 Throm (5.), 1:2 Throm (23./EM), 2:2 Aichberger (66.), 3:2 Leigh (80.), 3:3 Ritter (89.) Der Gautinger SC hat seine Serie fortgesetzt. „Wir sind jetzt das elfte Spiel in Folge ungeschlagen.

    By Michael Baumgartner Verified · TZ

    Apr. 07, 2025

  • Navigating parental hesitancy in public health: the case for RSV immunization in newborns - Journal of Perinatology

    By Michael Baumgartner Verified, Mara Schneider, Henrike Rieger| Nature Verified AbstractRespiratory syncytial virus (RSV) poses a significant risk to newborns, particularly during the first months of life, and remains a leading cause of pediatric hospitalization in Germany. Despite the approval of innovative immunoprophylaxis methods like nirsevimab, parental hesitancy persists, driven by knowledge gaps and concerns about safety.

    By Michael Baumgartner Verified, Mara Schneider, Henrike Rieger · Nature

    Apr. 10, 2025

As seen in

Company Info

ALPENFEUILLETON